Angiotensin-receptor blocker (ARB) therapy may cut the risk of Alzheimer’s disease by reducing amyloid deposition in the brain.
“To our knowledge, this is the first human evidence to suggest that treatment with ARBs may have a selective beneficial effect on amyloid metabolism,” De. Ihab Hajjar, and colleagues from University of Southern California – Los Angeles, reported.
Earlier this year, Hajjar’s group reported results of a small study suggesting that ARB therapy may improve cognitive function in older adults with early cognitive impairment.
This is the first time that a mechanism for the ARB’s protective effect, but not the first observation that it can be potentially preventive in Alzheimer’s. Several research teams have found evidence that ARB therapy may protect against cognitive decline and dementia.
In 2010, as reported by Medscape Medical News, a study by Dr. Wolozin and colleagues found a significant reduction in the incidence of Alzheimer’s and dementia among ARB users compared with users of angiotensin-converting enzyme (ACE) inhibitors or other cardiovascular drugs. The risk for Alzheimer’s was 24 percent lower in those prescribed ACE inhibitors.
In 2011, a large British study confirmed this result, finding a 53 percent lower risk for AD in older adults prescribed an ARB compared with those prescribed other antihypertensive agents.
I tell my patients to add ARBs to coffee and coconut oil as possible agents to decrease the risk of Alzheimer’s dementia. For those with hypertension, diabetes (ARBs also protect diabetic kidneys) or congestive heart failure (ARBs are typically part of the treatment regimen) clearly an ARB should be included in therapy, even though the data is not entirely clear.
Its use, based on this data, especially in those at high risk for Alzheimer’s (like a family history of dementia) is compelling. The question is, should we prescribe the drug to others who are at high risk?
Every drug has side effects and there is also the question of cost (many ARBs are now available in generics and so cost should not be the deciding factor any more). This needs to be decided by the primary care doctor, nurse practitioner and/or neurologist.
Here is a list of ARBs:
Candesartan – Atacand
Eprosartan – Teveten
Irbesartan – Avapro
Losartan – Cozaar
Olmesartan – Benicar (Benicar has been associated with abdominal pain, cramping and diarrhea)
Telmisartan – Micardis
Valsartan – Diovan
- Skin Cancer in Arizona: Stats, facts and new immunotherapy drugs making strides
- Caring Crisis: Rising tide In Alzheimer’s disease leads to shortage of caregivers
- Distracted walking injuries end up not so funny
- Scary situations: 5 quick tips before you let a contractor in your home
- Four ways telemedicine is changing the health care industry
- 5 mistakes homeowners make in the spring
- Three rivers run through it: Exploring Arizona's waterways
- Smart home basics: things you need to know to get started
- 5 Surprising things causing back pain
- Arizona agriculture is a $17.1B industry
- Timeline: Arizona's roots in brewing history
- 5 reasons to love the D-backs this season
- Tips for taking your home entertainment experience to the backyard
- Tech-related injuries your parents never experienced
- Workers comp: Signs your co-worker could be a fraud
- Who's the real founder of America's pastime?
- Epidemic rising? What you need to know about Alzheimer's in Arizona
- 5 unforgettable Wooden Award winners
- Family and hard work are keys to success of modern dairy farmers
- Genetic testing could hold answers for colon cancer survival
- Cold beers and baseball: A beer lover's guide to Spring Training
- Telecommuting: 5 tips to make it work for employers and employees
- See how top CFOs feel about economic growth in the Valley
- Migraine myths that keep patients from effective treatments
- Here’s why Gaydos went tankless with his water heater
- Bocce ball and basketball: How you can help Arizona's Special Olympics athletes
- Tips on building the best wine room in Arizona
- Avoid the nightmare: 6 tips to choose a great contractor
- Breast cancer: Improved testing and treatments means more survivors
- Failed back surgery: New hope for patients living in pain